Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes(LADA) (DPP-ⅣLADA)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Chinese Medical Association
Eli Lilly and Company
Information provided by:
European Foundation for the Study of Diabetes
ClinicalTrials.gov Identifier:
NCT01159847
First received: May 5, 2010
Last updated: July 9, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
No publications provided by European Foundation for the Study of Diabetes

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):